About Us
About us
Our Team
Partnerships
Development Programs
Development Overview
IHL-42X: Obstructive Sleep Apnoea
Psi-GAD: Psilocybin for anxiety
IHL-675A Rheumatoid Arthritis
IHL-675A: Inflammatory bowel disease
IHL-675A: Lung inflammation
IHL-216A: Concussion and TBI
CannQuit-N: Nicotine Addiction
CannQuit-O: Opioid Addiction
ReneCann: Vitiligo, Psoriasis, Eczema
Investors
NASDAQ Investor Centre
SEC Filings
Historical Company Announcements
Corporate Governance
Contact Us
Back
APIRx Pharmaceuticals Acquisition
Share this page
Further reading
Related news
